xenoview
Generic: xenon xe 129 hyperpolarized
Labeler: polarean, inc.Drug Facts
Product Profile
Brand Name
xenoview
Generic Name
xenon xe 129 hyperpolarized
Labeler
polarean, inc.
Dosage Form
GAS
Routes
Active Ingredients
xenon xe-129, hyperpolarized 75 mL/300mL
Manufacturer
Identifiers & Regulatory
Product NDC
80534-0300
Product ID
80534-0300_2d171c31-4d16-4bc1-9b90-b69631feadd5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA214375
Listing Expiration
2026-12-31
Marketing Start
2022-12-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
805340300
Hyphenated Format
80534-0300
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
xenoview (source: ndc)
Generic Name
xenon xe 129 hyperpolarized (source: ndc)
Application Number
NDA214375 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 75 mL/300mL
Packaging
- 50 BAG in 1 CARTON (80534-0300-1) / 300 mL in 1 BAG
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "2d171c31-4d16-4bc1-9b90-b69631feadd5", "openfda": {"nui": ["N0000194089", "N0000175862"], "unii": ["206GF3GB41", "N762921K75", "9C7571UDT5", "726Q6M95ZA"], "spl_set_id": ["70e33fe3-c722-439b-b3db-c2a22f229c8a"], "pharm_class_epc": ["Hyperpolarized Contrast Agent [EPC]"], "pharm_class_moa": ["Magnetic Resonance Contrast Activity [MoA]"], "manufacturer_name": ["Polarean, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 BAG in 1 CARTON (80534-0300-1) / 300 mL in 1 BAG", "package_ndc": "80534-0300-1", "marketing_start_date": "20250530"}], "brand_name": "XENOVIEW", "product_id": "80534-0300_2d171c31-4d16-4bc1-9b90-b69631feadd5", "dosage_form": "GAS", "pharm_class": ["Hyperpolarized Contrast Agent [EPC]", "Magnetic Resonance Contrast Activity [MoA]"], "product_ndc": "80534-0300", "generic_name": "xenon Xe 129 hyperpolarized", "labeler_name": "Polarean, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XENOVIEW", "active_ingredients": [{"name": "XENON XE-129, HYPERPOLARIZED", "strength": "75 mL/300mL"}], "application_number": "NDA214375", "marketing_category": "NDA", "marketing_start_date": "20221223", "listing_expiration_date": "20261231"}